Intercellular mRNA transfer alters the human pluripotent stem cell state
Abstract
Intercellular transmission of messenger RNA (mRNA) is being explored in mammalian species using immortal cell lines. Here, we uncover an intercellular mRNA transfer phenomenon that allows for the adaptation and reprogramming of human primed pluripotent stem cells (hPSCs). This process is induced by the direct cell contact-mediated coculture with mouse embryonic stem cells under the condition impermissible for primed hPSC culture. Mouse-derived mRNA contents are transmitted into adapted hPSCs only in the coculture. Transfer-specific mRNA analysis shows the enrichment for divergent biological pathways involving transcription/translational machinery and stress-coping mechanisms, wherein such transfer is diminished when direct cell contacts are lost. After 5 d of coculture with mouse embryonic stem cells, surface marker analysis and global gene profiling confirmed that mRNA transfer-prone hPSC efficiently gains a naïve-like state. Furthermore, transfer-specific knockdown experiments targeting mouse-specific transcription factor-coding mRNAs in hPSC show that mouse-derived Tfcp2l1 , Tfap2c, and Klf4 are indispensable for human naïve-like conversion. Thus, interspecies mRNA transfer triggers cellular reprogramming in mammalian cells. Our results support that episodic mRNA transfer can occur in cell cooperative and competitive processes, which provides a fresh perspective on understanding the roles of mRNA mobility for intra- and interspecies cellular communications.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (16)
Yosuke Yoneyama
Human Biology Research Unit, Institute of Integrated Research, Institute of Science Tokyo
Ran-Ran Zhang
Division of Gastroenterology, Hepatology & Nutrition, Cincinnati Children’s Hospital Medical Center
Mari Maezawa
Human Biology Research Unit, Institute of Integrated Research, Institute of Science Tokyo
Hideki Masaki
Stem Cell Therapy Division, Institute of Integrated Research, Institute of Science Tokyo
Masaki Kimura
Division of Gastroenterology, Hepatology & Nutrition, Cincinnati Children’s Hospital Medical Center
Yuqi Cai
Division of Gastroenterology, Hepatology & Nutrition, Cincinnati Children’s Hospital Medical Center
Mike Adam
Division of Gastroenterology, Hepatology & Nutrition, Cincinnati Children’s Hospital Medical Center
Sreeja Parameswaran
Center for Autoimmune Genomics and Etiology, Cincinnati Children’s Hospital Medical Center
Naoaki Mizuno
Stem Cell Therapy Division, Institute of Integrated Research, Institute of Science Tokyo
Joydeep Bhadury
Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine
So Maezawa
Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science
Hiroshi Ochiai
Division of Gene Expression Dynamics, Medical Institute of Bioregulation, Kyushu University
Hiromitsu Nakauchi
S. Steven Potter
Division of Gastroenterology, Hepatology & Nutrition, Cincinnati Children’s Hospital Medical Center
Matthew T. Weirauch
Division of Gastroenterology, Hepatology & Nutrition, Cincinnati Children’s Hospital Medical Center
Takanori Takebe